What is claimed is:
1. A method of treating an inflammatory disease in a subject comprising administering to the subject a therapeutically effective amount of a Slc5a12 inhibitor or a Slc16a1 inhibitor.
The present invention relates to the use of specific inhibitors of lactate transporters in the treatment of chronic inflammatory diseases. The invention also relates to methods of treatment of such diseases.